APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Health Product

Immune health products are health products that can improve immunity and promote metabolism.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Immune health products are health products that can improve immunity and promote metabolism.

Selected research

Market Analysis & Forecast

Global Immune Health Product Market Analysis and Forecast 2026-2032

29 December 2025194 pages

Choose your research edition.

Industry ResearchImmune Health Product Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Health Product Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Immune Health Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Health Product Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Health Product Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Immune health products are health products that can improve immunity and promote metabolism.

Global Immune Health Product key players include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe and China, both have a share over 37 percent. In terms of product, Capsule/Pills is the largest segment, with a share over 81%. And in terms of End User, the largest End User is Adults, followed by Men, etc.

Report Includes

Read the full market overview

This report presents an overview of global market for Immune Health Product, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immune Health Product, also provides the revenue of main regions and countries. Of the upcoming market potential for Immune Health Product, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune Health Product revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immune Health Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Immune Health Product revenue, projected growth trends, production technology, application and end-user industry.

Immune Health Product Segment by Company

Amway

Suntory

GNC

INFINITUS

Herbalife Nutrition

USANA Health Sciences, Inc.

PERFECT

Nestlé SA

H&H Group

China New Era Group

By-health

Black Mores

Glanbia Plc

Nature’s

Real Nutriceutical

Immune Health Product Segment by Form

Capsule/Pills

Powder

Liquid

Immune Health Product Segment by End Users

Children/Teenagers

Men

Adults

The Elderly

Immune Health Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Health Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Immune Health Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Immune Health Product company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Health Product revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immune Health Product Market Size Growth Rate by Form (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule/Pills Major Player Table 3. Powder Major Player Table 4. Liquid Major Player Table 5. Global Immune Health Product Market Size Growth Rate by End Users (US$ Million), 2021 VS 2025 VS 2032 Table 6. Children/Teenagers Major Player Table 7. Men Major Player Table 8. Adults Major Player Table 9. The Elderly Major Player Table 10. Immune Health Product Industry Trends Table 11. Immune Health Product Industry Drivers Table 12. Immune Health Product Industry Opportunities and Challenges Table 13. Immune Health Product Industry Restraints Table 14. Global Immune Health Product Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Immune Health Product Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Immune Health Product Market Share by Region (2021-2026) Table 17. Global Immune Health Product Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Immune Health Product Market Share by Region (2027-2032) Table 19. Global Immune Health Product Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Immune Health Product Revenue Market Share by Players (2021-2026) Table 21. Global Immune Health Product Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Immune Health Product Key Players Headquarters & Area Served Table 23. Global Immune Health Product Players, Product Type & Application Table 24. Global Immune Health Product Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Immune Health Product by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Immune Health Product Revenue by Form 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Immune Health Product Revenue by Form (2021-2026) & (US$ Million) Table 29. Global Immune Health Product Revenue by Form (2027-2032) & (US$ Million) Table 30. Global Immune Health Product Revenue Market Share by Form (2021-2026) Table 31. Global Immune Health Product Revenue Market Share by Form (2027-2032) Table 32. Global Immune Health Product Revenue by End Users 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Immune Health Product Revenue by End Users (2021-2026) & (US$ Million) Table 34. Global Immune Health Product Revenue by End Users (2027-2032) & (US$ Million) Table 35. Global Immune Health Product Revenue Market Share by End Users (2021-2026) Table 36. Global Immune Health Product Revenue Market Share by End Users (2027-2032) Table 37. Amway Company Information Table 38. Amway Business Overview Table 39. Amway Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Amway Immune Health Product Product Portfolio Table 41. Amway Recent Development Table 42. Suntory Company Information Table 43. Suntory Business Overview Table 44. Suntory Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Suntory Immune Health Product Product Portfolio Table 46. Suntory Recent Development Table 47. GNC Company Information Table 48. GNC Business Overview Table 49. GNC Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. GNC Immune Health Product Product Portfolio Table 51. GNC Recent Development Table 52. INFINITUS Company Information Table 53. INFINITUS Business Overview Table 54. INFINITUS Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. INFINITUS Immune Health Product Product Portfolio Table 56. INFINITUS Recent Development Table 57. Herbalife Nutrition Company Information Table 58. Herbalife Nutrition Business Overview Table 59. Herbalife Nutrition Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Herbalife Nutrition Immune Health Product Product Portfolio Table 61. Herbalife Nutrition Recent Development Table 62. USANA Health Sciences, Inc. Company Information Table 63. USANA Health Sciences, Inc. Business Overview Table 64. USANA Health Sciences, Inc. Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. USANA Health Sciences, Inc. Immune Health Product Product Portfolio Table 66. USANA Health Sciences, Inc. Recent Development Table 67. PERFECT Company Information Table 68. PERFECT Business Overview Table 69. PERFECT Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. PERFECT Immune Health Product Product Portfolio Table 71. PERFECT Recent Development Table 72. Nestlé SA Company Information Table 73. Nestlé SA Business Overview Table 74. Nestlé SA Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Nestlé SA Immune Health Product Product Portfolio Table 76. Nestlé SA Recent Development Table 77. H&H Group Company Information Table 78. H&H Group Business Overview Table 79. H&H Group Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. H&H Group Immune Health Product Product Portfolio Table 81. H&H Group Recent Development Table 82. China New Era Group Company Information Table 83. China New Era Group Business Overview Table 84. China New Era Group Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. China New Era Group Immune Health Product Product Portfolio Table 86. China New Era Group Recent Development Table 87. By-health Company Information Table 88. By-health Business Overview Table 89. By-health Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. By-health Immune Health Product Product Portfolio Table 91. By-health Recent Development Table 92. Black Mores Company Information Table 93. Black Mores Business Overview Table 94. Black Mores Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Black Mores Immune Health Product Product Portfolio Table 96. Black Mores Recent Development Table 97. Glanbia Plc Company Information Table 98. Glanbia Plc Business Overview Table 99. Glanbia Plc Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Glanbia Plc Immune Health Product Product Portfolio Table 101. Glanbia Plc Recent Development Table 102. Nature’s Company Information Table 103. Nature’s Business Overview Table 104. Nature’s Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Nature’s Immune Health Product Product Portfolio Table 106. Nature’s Recent Development Table 107. Real Nutriceutical Company Information Table 108. Real Nutriceutical Business Overview Table 109. Real Nutriceutical Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Real Nutriceutical Immune Health Product Product Portfolio Table 111. Real Nutriceutical Recent Development Table 112. North America Immune Health Product Revenue by Form (2021-2026) & (US$ Million) Table 113. North America Immune Health Product Revenue by Form (2027-2032) & (US$ Million) Table 114. North America Immune Health Product Revenue by End Users (2021-2026) & (US$ Million) Table 115. North America Immune Health Product Revenue by End Users (2027-2032) & (US$ Million) Table 116. North America Immune Health Product Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Immune Health Product Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Immune Health Product Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Immune Health Product Revenue by Form (2021-2026) & (US$ Million) Table 120. Europe Immune Health Product Revenue by Form (2027-2032) & (US$ Million) Table 121. Europe Immune Health Product Revenue by End Users (2021-2026) & (US$ Million) Table 122. Europe Immune Health Product Revenue by End Users (2027-2032) & (US$ Million) Table 123. Europe Immune Health Product Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Immune Health Product Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Immune Health Product Revenue by Country (US$ Million) & (2027-2032) Table 126. China Immune Health Product Revenue by Form (2021-2026) & (US$ Million) Table 127. China Immune Health Product Revenue by Form (2027-2032) & (US$ Million) Table 128. China Immune Health Product Revenue by End Users (2021-2026) & (US$ Million) Table 129. China Immune Health Product Revenue by End Users (2027-2032) & (US$ Million) Table 130. Asia Immune Health Product Revenue by Form (2021-2026) & (US$ Million) Table 131. Asia Immune Health Product Revenue by Form (2027-2032) & (US$ Million) Table 132. Asia Immune Health Product Revenue by End Users (2021-2026) & (US$ Million) Table 133. Asia Immune Health Product Revenue by End Users (2027-2032) & (US$ Million) Table 134. Asia Immune Health Product Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Immune Health Product Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Immune Health Product Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Immune Health Product Revenue by Form (2021-2026) & (US$ Million) Table 138. SAMEA Immune Health Product Revenue by Form (2027-2032) & (US$ Million) Table 139. SAMEA Immune Health Product Revenue by End Users (2021-2026) & (US$ Million) Table 140. SAMEA Immune Health Product Revenue by End Users (2027-2032) & (US$ Million) Table 141. SAMEA Immune Health Product Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Immune Health Product Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Immune Health Product Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Immune Health Product Image Figure 2. Global Immune Health Product Market Size Growth Rate by Form (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Health Product Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule/Pills Image Figure 5. Powder Image Figure 6. Liquid Image Figure 7. Global Immune Health Product Market Size Growth Rate by End Users (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Immune Health Product Market Size Share 2021 VS 2025 VS 2032 Figure 9. Children/Teenagers Image Figure 10. Men Image Figure 11. Adults Image Figure 12. The Elderly Image Figure 13. Global Immune Health Product Market Size (US$ Million) & (2021-2032) Figure 14. Global Immune Health Product Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Immune Health Product Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Immune Health Product Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Immune Health Product Revenue by Form (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Immune Health Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Immune Health Product Revenue Market Share by Form (2021-2032) Figure 21. Global Immune Health Product Revenue by End Users (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Immune Health Product Revenue Market Share by End Users (2021 VS 2025 VS 2032) Figure 23. Global Immune Health Product Revenue Market Share by End Users (2021-2032) Figure 24. North America Immune Health Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Immune Health Product Revenue Share by Type (2021-2032) Figure 26. North America Immune Health Product Revenue Share by Application (2021-2032) Figure 27. North America Immune Health Product Revenue Share by Country (2021-2032) Figure 28. United States Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Immune Health Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Immune Health Product Revenue Share by Type (2021-2032) Figure 33. Europe Immune Health Product Revenue Share by Application (2021-2032) Figure 34. Europe Immune Health Product Revenue Share by Country (2021-2032) Figure 35. Germany Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Immune Health Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Immune Health Product Revenue Share by Type (2021-2032) Figure 45. China Immune Health Product Revenue Share by Application (2021-2032) Figure 46. Asia Immune Health Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Immune Health Product Revenue Share by Type (2021-2032) Figure 48. Asia Immune Health Product Revenue Share by Application (2021-2032) Figure 49. Asia Immune Health Product Revenue Share by Region (2021-2032) Figure 50. Japan Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Immune Health Product Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Immune Health Product Revenue Share by Type (2021-2032) Figure 58. SAMEA Immune Health Product Revenue Share by Application (2021-2032) Figure 59. SAMEA Immune Health Product Revenue Share by Country (2021-2032) Figure 60. Brazil Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Immune Health Product Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule/Pills
  • Powder
  • Liquid
Applications
  • Children/Teenagers
  • Men
  • Adults
  • The Elderly
Companies covered
  • Amway
  • Suntory
  • GNC
  • INFINITUS
  • Herbalife Nutrition
  • USANA Health Sciences, Inc.
  • PERFECT
  • Nestlé SA
  • H&H Group
  • China New Era Group
  • By-health
  • Black Mores
  • Glanbia Plc
  • Nature’s
  • Real Nutriceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immune Health Product Market by Form
  3. 1.2.1 Global Immune Health Product Market Size by Form, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule/Pills
  5. 1.2.3 Powder
  6. 1.2.4 Liquid
  7. 1.3 Immune Health Product Market by End Users
  8. 1.3.1 Global Immune Health Product Market Size by End Users, 2021 VS 2025 VS 2032
  9. 1.3.2 Children/Teenagers
  10. 1.3.3 Men
  11. 1.3.4 Adults
  12. 1.3.5 The Elderly
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Immune Health Product Market Dynamics
  1. 2.1 Immune Health Product Industry Trends
  2. 2.2 Immune Health Product Industry Drivers
  3. 2.3 Immune Health Product Industry Opportunities and Challenges
  4. 2.4 Immune Health Product Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Immune Health Product Market Perspective (2021-2032)
  2. 3.2 Global Immune Health Product Growth Trends by Region
  3. 3.2.1 Global Immune Health Product Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immune Health Product Market Size by Region (2021-2026)
  5. 3.2.3 Global Immune Health Product Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Immune Health Product Revenue by Players
  2. 4.1.1 Global Immune Health Product Revenue by Players (2021-2026)
  3. 4.1.2 Global Immune Health Product Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Immune Health Product Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immune Health Product Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Immune Health Product Key Players Headquarters & Area Served
  7. 4.4 Global Immune Health Product Players, Product Type & Application
  8. 4.5 Global Immune Health Product Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Immune Health Product Market CR5 and HHI
  11. 4.6.3 2025 Immune Health Product Tier 1, Tier 2, and Tier 3
5 Immune Health Product Market Size by Type
  1. 5.1 Global Immune Health Product Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Immune Health Product Revenue by Type (2021-2032)
  3. 5.3 Global Immune Health Product Revenue Market Share by Type (2021-2032)
6 Immune Health Product Market Size by Application
  1. 6.1 Global Immune Health Product Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Immune Health Product Revenue by Application (2021-2032)
  3. 6.3 Global Immune Health Product Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Amway
  2. 7.1.1 Amway Company Information
  3. 7.1.2 Amway Business Overview
  4. 7.1.3 Amway Immune Health Product Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Amway Immune Health Product Product Portfolio
  6. 7.1.5 Amway Recent Developments
  7. 7.2 Suntory
  8. 7.2.1 Suntory Company Information
  9. 7.2.2 Suntory Business Overview
  10. 7.2.3 Suntory Immune Health Product Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Suntory Immune Health Product Product Portfolio
  12. 7.2.5 Suntory Recent Developments
  13. 7.3 GNC
  14. 7.3.1 GNC Company Information
  15. 7.3.2 GNC Business Overview
  16. 7.3.3 GNC Immune Health Product Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GNC Immune Health Product Product Portfolio
  18. 7.3.5 GNC Recent Developments
  19. 7.4 INFINITUS
  20. 7.4.1 INFINITUS Company Information
  21. 7.4.2 INFINITUS Business Overview
  22. 7.4.3 INFINITUS Immune Health Product Revenue and Gross Margin (2021-2026)
  23. 7.4.4 INFINITUS Immune Health Product Product Portfolio
  24. 7.4.5 INFINITUS Recent Developments
  25. 7.5 Herbalife Nutrition
  26. 7.5.1 Herbalife Nutrition Company Information
  27. 7.5.2 Herbalife Nutrition Business Overview
  28. 7.5.3 Herbalife Nutrition Immune Health Product Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Herbalife Nutrition Immune Health Product Product Portfolio
  30. 7.5.5 Herbalife Nutrition Recent Developments
  31. 7.6 USANA Health Sciences, Inc.
  32. 7.6.1 USANA Health Sciences, Inc. Company Information
  33. 7.6.2 USANA Health Sciences, Inc. Business Overview
  34. 7.6.3 USANA Health Sciences, Inc. Immune Health Product Revenue and Gross Margin (2021-2026)
  35. 7.6.4 USANA Health Sciences, Inc. Immune Health Product Product Portfolio
  36. 7.6.5 USANA Health Sciences, Inc. Recent Developments
  37. 7.7 PERFECT
  38. 7.7.1 PERFECT Company Information
  39. 7.7.2 PERFECT Business Overview
  40. 7.7.3 PERFECT Immune Health Product Revenue and Gross Margin (2021-2026)
  41. 7.7.4 PERFECT Immune Health Product Product Portfolio
  42. 7.7.5 PERFECT Recent Developments
  43. 7.8 Nestlé SA
  44. 7.8.1 Nestlé SA Company Information
  45. 7.8.2 Nestlé SA Business Overview
  46. 7.8.3 Nestlé SA Immune Health Product Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nestlé SA Immune Health Product Product Portfolio
  48. 7.8.5 Nestlé SA Recent Developments
  49. 7.9 H&H Group
  50. 7.9.1 H&H Group Company Information
  51. 7.9.2 H&H Group Business Overview
  52. 7.9.3 H&H Group Immune Health Product Revenue and Gross Margin (2021-2026)
  53. 7.9.4 H&H Group Immune Health Product Product Portfolio
  54. 7.9.5 H&H Group Recent Developments
  55. 7.10 China New Era Group
  56. 7.10.1 China New Era Group Company Information
  57. 7.10.2 China New Era Group Business Overview
  58. 7.10.3 China New Era Group Immune Health Product Revenue and Gross Margin (2021-2026)
  59. 7.10.4 China New Era Group Immune Health Product Product Portfolio
  60. 7.10.5 China New Era Group Recent Developments
  61. 7.11 By-health
  62. 7.11.1 By-health Company Information
  63. 7.11.2 By-health Business Overview
  64. 7.11.3 By-health Immune Health Product Revenue and Gross Margin (2021-2026)
  65. 7.11.4 By-health Immune Health Product Product Portfolio
  66. 7.11.5 By-health Recent Developments
  67. 7.12 Black Mores
  68. 7.12.1 Black Mores Company Information
  69. 7.12.2 Black Mores Business Overview
  70. 7.12.3 Black Mores Immune Health Product Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Black Mores Immune Health Product Product Portfolio
  72. 7.12.5 Black Mores Recent Developments
  73. 7.13 Glanbia Plc
  74. 7.13.1 Glanbia Plc Company Information
  75. 7.13.2 Glanbia Plc Business Overview
  76. 7.13.3 Glanbia Plc Immune Health Product Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Glanbia Plc Immune Health Product Product Portfolio
  78. 7.13.5 Glanbia Plc Recent Developments
  79. 7.14 Nature’s
  80. 7.14.1 Nature’s Company Information
  81. 7.14.2 Nature’s Business Overview
  82. 7.14.3 Nature’s Immune Health Product Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Nature’s Immune Health Product Product Portfolio
  84. 7.14.5 Nature’s Recent Developments
  85. 7.15 Real Nutriceutical
  86. 7.15.1 Real Nutriceutical Company Information
  87. 7.15.2 Real Nutriceutical Business Overview
  88. 7.15.3 Real Nutriceutical Immune Health Product Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Real Nutriceutical Immune Health Product Product Portfolio
  90. 7.15.5 Real Nutriceutical Recent Developments
8 North America
  1. 8.1 North America Immune Health Product Revenue (2021-2032)
  2. 8.2 North America Immune Health Product Revenue by Form (2021-2032)
  3. 8.2.1 North America Immune Health Product Revenue by Form (2021-2026)
  4. 8.2.2 North America Immune Health Product Revenue by Form (2027-2032)
  5. 8.3 North America Immune Health Product Revenue Share by Form (2021-2032)
  6. 8.4 North America Immune Health Product Revenue by End Users (2021-2032)
  7. 8.4.1 North America Immune Health Product Revenue by End Users (2021-2026)
  8. 8.4.2 North America Immune Health Product Revenue by End Users (2027-2032)
  9. 8.5 North America Immune Health Product Revenue Share by End Users (2021-2032)
  10. 8.6 North America Immune Health Product Revenue by Country
  11. 8.6.1 North America Immune Health Product Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Immune Health Product Revenue by Country (2021-2026)
  13. 8.6.3 North America Immune Health Product Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Immune Health Product Revenue (2021-2032)
  2. 9.2 Europe Immune Health Product Revenue by Form (2021-2032)
  3. 9.2.1 Europe Immune Health Product Revenue by Form (2021-2026)
  4. 9.2.2 Europe Immune Health Product Revenue by Form (2027-2032)
  5. 9.3 Europe Immune Health Product Revenue Share by Form (2021-2032)
  6. 9.4 Europe Immune Health Product Revenue by End Users (2021-2032)
  7. 9.4.1 Europe Immune Health Product Revenue by End Users (2021-2026)
  8. 9.4.2 Europe Immune Health Product Revenue by End Users (2027-2032)
  9. 9.5 Europe Immune Health Product Revenue Share by End Users (2021-2032)
  10. 9.6 Europe Immune Health Product Revenue by Country
  11. 9.6.1 Europe Immune Health Product Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Immune Health Product Revenue by Country (2021-2026)
  13. 9.6.3 Europe Immune Health Product Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Immune Health Product Revenue (2021-2032)
  2. 10.2 China Immune Health Product Revenue by Form (2021-2032)
  3. 10.2.1 China Immune Health Product Revenue by Form (2021-2026)
  4. 10.2.2 China Immune Health Product Revenue by Form (2027-2032)
  5. 10.3 China Immune Health Product Revenue Share by Form (2021-2032)
  6. 10.4 China Immune Health Product Revenue by End Users (2021-2032)
  7. 10.4.1 China Immune Health Product Revenue by End Users (2021-2026)
  8. 10.4.2 China Immune Health Product Revenue by End Users (2027-2032)
  9. 10.5 China Immune Health Product Revenue Share by End Users (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immune Health Product Revenue (2021-2032)
  2. 11.2 Asia Immune Health Product Revenue by Form (2021-2032)
  3. 11.2.1 Asia Immune Health Product Revenue by Form (2021-2026)
  4. 11.2.2 Asia Immune Health Product Revenue by Form (2027-2032)
  5. 11.3 Asia Immune Health Product Revenue Share by Form (2021-2032)
  6. 11.4 Asia Immune Health Product Revenue by End Users (2021-2032)
  7. 11.4.1 Asia Immune Health Product Revenue by End Users (2021-2026)
  8. 11.4.2 Asia Immune Health Product Revenue by End Users (2027-2032)
  9. 11.5 Asia Immune Health Product Revenue Share by End Users (2021-2032)
  10. 11.6 Asia Immune Health Product Revenue by Country
  11. 11.6.1 Asia Immune Health Product Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Immune Health Product Revenue by Country (2021-2026)
  13. 11.6.3 Asia Immune Health Product Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immune Health Product Revenue (2021-2032)
  2. 12.2 SAMEA Immune Health Product Revenue by Form (2021-2032)
  3. 12.2.1 SAMEA Immune Health Product Revenue by Form (2021-2026)
  4. 12.2.2 SAMEA Immune Health Product Revenue by Form (2027-2032)
  5. 12.3 SAMEA Immune Health Product Revenue Share by Form (2021-2032)
  6. 12.4 SAMEA Immune Health Product Revenue by End Users (2021-2032)
  7. 12.4.1 SAMEA Immune Health Product Revenue by End Users (2021-2026)
  8. 12.4.2 SAMEA Immune Health Product Revenue by End Users (2027-2032)
  9. 12.5 SAMEA Immune Health Product Revenue Share by End Users (2021-2032)
  10. 12.6 SAMEA Immune Health Product Revenue by Country
  11. 12.6.1 SAMEA Immune Health Product Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Immune Health Product Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Immune Health Product Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst